GLP-1 Receptor Stimulation Reduces Amyloid-beta Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer’s Disease

Manuscript Number: 

9-1129R1

Author(s): 
Jason A. Bailey, Kara B. Duffy, Nigel H. Greig, Harold W. Holloway, Dimitrios Kapogiannis, Debomoy K. Lahiri, Yazhou Li, Mark P. Mattson, Mary Ann Ottinger, TracyAnn Perry, Balmiki Ray, Kumar Sambamurti, David Tweedie

Disclosures

Jason A. Bailey

  • Nothing to Disclose

Kara B. Duffy

  • Nothing to Disclose

Nigel H. Greig

  • Equity:
    I provide a full financial disclosure to NIH annually relating to myself and family - and have no conflicts of interest according to NIH criteria.
    Patents/Royalties
    All patents that derive from my research belong entirely to the NIH.

Harold W. Holloway

  • Nothing to Disclose

Dimitrios Kapogiannis

  • Nothing to Disclose

Debomoy K. Lahiri

  • Nothing to Disclose

Yazhou Li

  • Nothing to Disclose

Mark P. Mattson

  • Nothing to Disclose

Mary Ann Ottinger

  • Nothing to Disclose

TracyAnn Perry

  • Equity:
    Amylin Pharmaceuticals stock options. I was employed at the NIH while contributing to the studies disclosed in this manscript. I have subsequently moved to a position in industry

Balmiki Ray

  • Nothing to Disclose

Kumar Sambamurti

  • Nothing to Disclose

David Tweedie

  • Nothing to Disclose